Sertraline is more effective than imipramine in the treatment of non-melancholic depression: results from a multicentre, randomized study
by
Baca E, Gonzalez de Chavez M,
Garcia-Toro M, Perez-Arnau F, Porras-Chavarino A.
Department of Psychiatry,
Hospital Puerta de Hierro, Madrid, Spain.
Prog Neuropsychopharmacol Biol Psychiatry. 2003 May;27(3):493-500


ABSTRACT

The acute treatment efficacy, tolerability, and effects on health-related quality of life of sertraline (50-200 mg/day) versus imipramine (75-225 mg/day) were compared in outpatients with non-melancholic depression. The study employed an open-label, parallel-group design. One hundred and sixteen patients were randomized to receive sertraline and 123 to receive imipramine for 8 weeks. In the intent-to-treat (ITT), last-observation-carried-forward (LOCF) analysis, sertraline produced statistically significantly greater improvements in depressive (21-item Hamilton Depression Rating Scale [HAM-D(21)] scores of 24.9 and 24.4 were reduced to 10.3 and 13.1 at endpoint, P<.005) and anxiety symptoms (Hamilton Anxiety Rating Scale [HAM-A] scores of 21.8 and 21.9 were reduced to 9.5 and 13.9, P<.01), as well as in response (69.0% versus 53.7% at endpoint, P=.016) and remission rates (51.3% versus 38.0% at endpoint, P=.041) from week 4 onwards compared with imipramine. The proportion of patients who were 'very much improved' or 'much improved' (Clinical Global Impressions Scale of Improvement [CGI-I] score of 1 or 2) was significantly higher at endpoint in the sertraline group (76.1%) than in the imipramine group (62.8%) (P=.028). At week 8, patients in both treatment groups showed clear improvements in quality of life, although nonstatistically significant differences were evident in the quality of life of sertraline- versus imipramine-treated patients. Sertraline was significantly superior in tolerability with less discontinuations due to adverse events (10.3%) compared with the imipramine group (24.4%) (P=.004). It was concluded that sertraline is more effective than imipramine in the acute treatment of depressive and anxiety symptoms in patients with non-melancholic depression.
TCAs
SSRIs
Options
Imipramine
Melancholia
Sertraline dosage
Sertraline and sex
Sertraline and OCD
Long-term sertraline
Sertraline v fluoxetine
Sertraline v amisulpride
Sertraline v mirtazapine
Sertraline and depression
Sertraline and noradrenaline
Sertraline for elderly depressives
Sertraline and personality disorders
Sertraline and psychomotor performance
SSRIs: fluoxetine (Prozac) versus sertraline (Zoloft, Lustral)


Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family